Business News
Home > Business News
Tata Capital Growth to invest Rs 225 cr in Biocon Biologics
TIWN
TIWN
PHOTO : TIWN
Bengaluru, Aug 1 (TIWN) Tata Capital Growth Fund will invest Rs 225 crore in Biocon Biologics India Ltd for an equity stake of 0.85 per cent.
The firm said this deal values Biocon Biologics at USD 3.5 billion.
In a regulatory filing, Biocon said the board of its subsidiary Biocon Biologics India has approved a primary equity investment by Tata Capital Growth Fund.
As per the terms of the proposed agreement, Tata Capital will invest USD 30 million ( ₹225 crore) for a 0.85 per cent minority stake in the biosimilar business.
Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.
Add your Comment
Comments (0)
More Business News
- Govt directs NCCF, NAFED to start buying 5 lakh tonnes of onion directly from farmers
- Adani Green Energy Gallery in UK to explore sustainable energy options to fight climate change
- Elon Musk thought that OpenAI would fail: Sam Altman
- India’s forex reserves surge for 3rd week in row to touch $642.5 billion mark
- DGCA imposes Rs 80 lakh fine on Air India for flight duty timing violations